Novo Nordisk has announced that the Food and Drug Administration (FDA) has approved semaglutide (Ozempic) to reduce the risk ...

Sangamo (SGMO) reported positive updated data from a Phase 1/2 study of its gene therapy candidate ST-920 in the treatment of Fabry disease. Read more here.

There is no specific treatment unequivocally shown to ... Severe CKD requires one of the forms of renal replacement therapy; this may be a form of dialysis, but ideally constitutes a kidney ...

We demonstrate here that administration of a CD154-specific monoclonal antibody (hu5C8) allows for renal allotransplantation ... antibody as the sole therapy. This treatment leads to a state ...

"We look forward to the results and plan to educate the public over the next few months on the importance of the planned biomarkers as it relates to CKD treatment and prevention of AKI." ...

Until now, while continuous renal replacement therapy (CRRT) has been utilized in the management ... Similarly, the identification of specific biomarkers and pharmacological targets for the treatment ...

Serial data were compared within and between groups by repeated measures analysis of variance, with a ‘between groups’ and a ‘repeated measures’ comparison ... end-stage renal failure and required ...

Further, the contours were applied to voxel dose maps computed from post-treatment quantitative SPECT imaging to estimate renal radiation dose ... in unsealed source therapy relative to a human ...

Otherwise, AKI care is primarily supportive, focused on treatment of the underlying cause, prevention of further injury, management of complications, and short-term renal replacement therapy in case ...

It can be useful as a guide to therapy, as it is expected to resolve with fluid and caloric replacement ... a sign of significant disease such as a renal or urinary malignancy.